Litcius/Paper detail

Immune checkpoint inhibitors in mesothelioma: a turning point

Giovanni Luca Ceresoli, Giulia Pasello

2021The Lancet16 citationsDOI

Topics & Concepts

MedicinePemetrexedMesotheliomaNivolumabOncologyInternal medicineIpilimumabGuidelineChemotherapyCancerPathologyImmunotherapyCisplatinOccupational and environmental lung diseasesPleural and Pulmonary DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis